Patents by Inventor Andre Pillez

Andre Pillez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7655406
    Abstract: The invention concerns the use of cells capable of carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome, such as prenylation of the NS5A protein, for replicating and, if required, the production of HCV or derivative viable mutants, in a suitable culture medium.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: February 2, 2010
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Czeslaw Wychowski, Gilles Duverlie, Jean Dubuisson, Andre Pillez
  • Publication number: 20080220410
    Abstract: The invention concerns the use of cells capable of carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome, such as prenylation of the NS5A protein, for replicating and, if required, the production of HCV or derivative viable mutants, in a suitable culture medium.
    Type: Application
    Filed: October 2, 2007
    Publication date: September 11, 2008
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Czeslaw Wychowski, Gilles Duverlie, Jean Dubuisson, Andre Pillez
  • Publication number: 20040142320
    Abstract: The invention concerns the use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome, such as prenylation of the NS5A protein, for replicating and, if required, the production of HCV or derivative viable mutants, in a suitable culture medium.
    Type: Application
    Filed: March 9, 2004
    Publication date: July 22, 2004
    Inventors: Czeslaw Wychowski, Gilles Duverlie, Jean Dubuisson, Andre Pillez